Clinical trial
Study of SPARC1103 in Subjects With Spasticity
NCT02027025 is registered in ClinicalTrials.gov with Sun Pharma Advanced Research Company Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of SPARC1103 in Subjects With Spasticity
- Lead sponsor
- Sun Pharma Advanced Research Company Limited
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 21, 2014
- Completion date
- April 28, 2017
- Enrollment
- 142 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
spasticity